Evidence map›Paper›PMID 41376829›Full record

ArticleFrontiers in health services2025

Complication development trajectories for patients with type 2 diabetes mellitus: evidence from a five-million retrospective cohort study.

Haoqing Tang, Mingyue Li, Xiaokang Ji, Qingbo Zhao, Yongchao Wang, Yifu Zhao, Qing Wang, Fuzhong Xue, Xiaoyun Liu

Abstract read
In one paragraph

Article in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haoqing TangDepartment of Health Policy and Management, School of Public Health, Peking University, Beijing, China.
Mingyue LiDepartment of Health Policy and Management, School of Public Health, Peking University, Beijing, China.
Xiaokang JiSchool of Public Health, Shandong University, Jinan, Shandong, China.
Qingbo ZhaoSchool of Public Health, Shandong University, Jinan, Shandong, China.
Yongchao WangSchool of Public Health, Shandong University, Jinan, Shandong, China.
Yifu ZhaoSchool of Public Health, Shandong University, Jinan, Shandong, China.
Qing WangSchool of Public Health, Shandong University, Jinan, Shandong, China.
Fuzhong XueSchool of Public Health, Shandong University, Jinan, Shandong, China.
Xiaoyun LiuChina Center for Health Development Studies, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a growing health burden in China. High complication rates contribute to increased morbidity, mortality, and costs. However, evidence is limited regarding how these complications develop and cluster over time in real-world settings, which this study examined. Methods: This retrospective cohort study used big data from the Cheeloo Lifespan Electronic Health Research Data Library, comprising data from over 5 million individuals in Shandong Province, China, to investigate the trajectories, onset timing and key risk factors of T2DM-related complications. Results: The prevalence of T2DM-related complications increased from 30.4% in 2013 to 53.1% in 2023. The median time from diagnosis to the first complication was 7.5 years. Ophthalmic, neurological, and circulatory complications were among the most common and showed the largest relative increases in prevalence over the study period. Complication profiles exacerbated over time: most patients developed multiple complications by Year 9. Frequent follow-up visits (≥4 times/year) and using primary health care (PHC) services were significantly associated with a reduced risk of complications, whereas being unmarried, being overweight, being obese, alcohol use, and poor medication adherence were significantly associated with a higher risk. Conclusion: Patients with T2DM in China face a substantial and growing burden of complications, with most developing multiple complications within ten years of diagnosis. Follow-up visits, the use of PHC services, and regular medication adherence are potential protective factors to prevent or delay the development of complication. These findings highlight the importance of integrated, community-based, and personalized management strategies to improve outcomes in T2DM populations.

Indexed as

cohort studycomplicationsPHCtrajectoriestype 2 diabetes mellitus

Identifiers

PMID41376829
PMCPMC12685925

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.